There were significant correlations between MYH10+/MYH9+ expression and the following factors (Table 1), such as FIGO stage (p < 0.0001), intraperitoneal metastasis (p < 0.0001), intestinal metastasis (p = 0.0076), ascites with tumor cells (p = 0.0012), and serum HE4 levels (p = 0.0275). Here, WFDC2 is linked to neoplasm.